Harvard Professor and Entrepreneur Tim Springer Donates $210 Million to the Institute for Protein Innovation
Retrieved on:
Wednesday, May 24, 2023
Science, Biotechnology, Research, Pharmaceutical, Health, Infectious Diseases, Genetics, Other Health, Takeda Pharmaceutical Company, Informatics, Nobel Prize, Vedolizumab, University, Human genome, Therapy, Doctor of Philosophy, Berkeley, Boston Children's Hospital, Biomedical Research, Disease, Genomics, Genome, Cell, Antibody, Harvard Medical School, Protein, Albert Lasker Award for Basic Medical Research, Patient, Human, Takeda Oncology, Integrin, IPI, Springer, ARD International Music Competition, Biology, Growth, Hospital, Human Genome Project, Gene, Pharmaceutical industry, Fine chemical, Vaccine
The Institute for Protein Innovation (IPI) , a nonprofit research organization, announced today a $210 million gift from Tim Springer, Ph.D., veteran entrepreneur and professor at Harvard Medical School and Boston Children’s Hospital, who founded IPI in 2017 with Andrew Kruse, Ph.D.
Key Points:
- The Institute for Protein Innovation (IPI) , a nonprofit research organization, announced today a $210 million gift from Tim Springer, Ph.D., veteran entrepreneur and professor at Harvard Medical School and Boston Children’s Hospital, who founded IPI in 2017 with Andrew Kruse, Ph.D.
- The philanthropic gift—made by Springer, his wife Chafen Lu, Ph.D., and their children—adds to previous gifts of $40 million to IPI from Springer himself.
- “Thanks to Tim’s commitment, IPI will be able to take on more challenging problems in protein science that academia and industry cannot or will not.
- Springer has previously endowed professorships and chairs at Harvard Medical School, Boston Children's Hospital and the University of California, Berkeley.